NCT06068088

Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET)

Preliminary Survey of Dietary Practices and Nutritional Status of Patients Treated With Radiochemotherapy for Non-small Cell Lung Carcinoma
Assistance Publique - Hôpitaux de Paris·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov
Study focus
Drug/Device/Intervention
Self-administered survey at hospital
Study type
Observational
Intervention type
behavioral
Sponsor & location
Primary sponsor
Assistance Publique - Hôpitaux de Paris
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2023
End date
Feb 01, 2025
Enrollment
120 participants
Primary outcome

Inventory of the dietary practices

Summary

In recent years, fasting or the use of special diets (ketogenic, high protein, etc.), whether
 or not associated with food supplements, have increased substantially, particularly in
 oncology with the idea of improving for some of them, the tolerance of the proposed
 treatments, in particular emetogenic chemotherapy, or even to improve the prognosis. Although
 there are preclinical data on cell cultures and in rats, the clinical data supporting these
 practices are very fragmented, with few trials carried out and only including small cohorts,
 mainly in the context of breast cancers. It is therefore very difficult to respond
 objectively to patients asking the question of the merits of these changes in dietary
 practices in the management of their cancer.
 
 The investigators want to carry out an inventory of the dietary practices of participating
 patients and their potential interest in fasting or special diets by means of a
 self-administered survey completed by the patient at diagnosis before treatment. This
 semi-quantitative self-administered survey (answers in never / sometimes / regularly /
 systematically) was developed by the nutrition and radiotherapy team of the Georges-Pompidou
 European Hospital because there was no validated medical questionnaire on fasting or the use
 of special diets in oncology

ICD-10 classifications
Carcinoma in situ: Bronchus and lungSecondary malignant neoplasm of lungMalignant neoplasm: Lower lobe, bronchus or lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm of bronchus and lung
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06068088
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06068088 through Pure Global AI's free database. This phase not specified trial is sponsored by Assistance Publique - Hôpitaux de Paris and is currently Not yet recruiting. The study focuses on Carcinoma, Non-Small-Cell Lung. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.